Intralink Spine???s R??juve Treatment Nears Completion Of Safety Study And Begins Multi-Site Pivotal Study Post author:Sam Post published:January 30, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like “An Unrelenting Disaster Zone”: Merck’s Alzheimer’s Drug Fails in Phase III February 13, 2018 Acorda Investor Urges for Company to Explore Sale August 6, 2017 This is the Drug That Could Kick Regeneron's Stock Into Gear December 13, 2017